Replies to post #92363 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Carbapenem resistant bugs(Enterobacter)in the news recently are gm negative. Brilacidin likely has little or no activity against this bug, and the other CTIX drugs that might be relevant are far far away from clinical use.

[John B]

I had mentioned a couple of weeks ago, that things might be quiet for a while. Not saying this is the reason why there is a lack of PRs, but this could be one of many possible explanations:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110679493

Monday, 02/09/15 07:38:01 AM
"I would not be surprised if Leo does not release much news before uplisting. Why release good news while you are on the OTC/pinks, where there is such low visibility? That is my thinking anyways... Also IMO, uplisting, and news in early March would counter any Aruda worries out there."

[BonelessCat]

Maybe one reason for the lack of press releases and silence has nothing to do with a quiet period, etc. If you are in the midst of a negiotiation, regarding licensing, partnership and maybe an equity stake kicker, maybe, just maybe, if its important to the company, in an effort to be forthright, honest and sincere, you would not release press releases to try to boost the stock price, while negiotating an equity kicker. Especially on a thinly traded stock like CTIX.

I believe that what you just described is one scenario for a quiet period.